interaction records 54 assistance programs 55 0 personal data stored

Recorded fact · program.covers_drug

program.covers_drug for pfizer-rxpathways

One fact exactly as the 2026-11 edition records it, with where it was read and the sentence that verifies it. This is the page an OmniRx receipt for fact f85cda8f resolves to.

The record

Fact idf85cda8f88783ee80deca94f
Entityprogram: pfizer-rxpathways
Fieldprogram.covers_drug
Sourcewww.pfizerrxpathways.com
Read on2026-11-08T03:25:27.706Z
Source versionpapwire-20261108T032101Z
Methodextract
Verificationverified
Licencefacts only (numbers, dates, statuses, hashes); no prose copied; attribution by URL
Edition2026-11, Merkle root 006ab9a329709cbe...

The verifying quote

What products will remain within Pfizer PAP as of January 1, 2026? Type Primary Care Specialty Care Oncology Medicines Celontin Depo-Estradiol Duavee Estring Norpace CR Nurtec Premarin Premphase Prempro Tikosyn Zarontin Zavzpret BeneFIX Cibinqo Elelyso Eucrisa Litfulo Somavert Velsipity Vyndamax Xeljanz (no new patients starting July 1, 2026) Xyntha Besponsa Bosulif (no new patients starting July 1, 2026) Braftovi Daurismo Ibrance Inlyta Lorbrena Mektovi Mylotarg Talzenna Xalkori Vaccines Abrysvo Comirnaty Penbraya Prevnar 20 Trumenba NOTE: This list of products is subject to change

Shown with dashes as hyphens. SHA-256 of the exact stored quote: 73a3be51ec04b2f89f1fefdc3923639115f3c78c6c63946a161ed71acd2be5d0.

The value

{
 "programName": "Pfizer RxPathways (Pfizer Patient Assistance Program)",
 "sponsor": "Pfizer",
 "listKind": "products remaining within Pfizer PAP as of January 1, 2026",
 "asOf": "2026-01-01",
 "drugs": [
  {
   "name": "Celontin"
  },
  {
   "name": "Depo-Estradiol"
  },
  {
   "name": "Duavee"
  },
  {
   "name": "Estring"
  },
  {
   "name": "Norpace CR"
  },
  {
   "name": "Nurtec"
  },
  {
   "name": "Premarin"
  },
  {
   "name": "Premphase"
  },
  {
   "name": "Prempro"
  },
  {
   "name": "Tikosyn"
  },
  {
   "name": "Zarontin"
  },
  {
   "name": "Zavzpret"
  },
  {
   "name": "BeneFIX"
  },
  {
   "name": "Cibinqo"
  },
  {
   "name": "Elelyso"
  },
  {
   "name": "Eucrisa"
  },
  {
   "name": "Litfulo"
  },
  {
   "name": "Somavert"
  },
  {
   "name": "Velsipity"
  },
  {
   "name": "Vyndamax"
  },
  {
   "name": "Xeljanz",
   "note": "no new patients starting July 1, 2026"
  },
  {
   "name": "Xyntha"
  },
  {
   "name": "Besponsa"
  },
  {
   "name": "Bosulif",
   "note": "no new patients starting July 1, 2026"
  },
  {
   "name": "Braftovi"
  },
  {
   "name": "Daurismo"
  },
  {
   "name": "Ibrance"
  },
  {
   "name": "Inlyta"
  },
  {
   "name": "Lorbrena"
  },
  {
   "name": "Mektovi"
  },
  {
   "name": "Mylotarg"
  },
  {
   "name": "Talzenna"
  },
  {
   "name": "Xalkori"
  },
  {
   "name": "Abrysvo"
  },
  {
   "name": "Comirnaty"
  },
  {
   "name": "Penbraya"
  },
  {
   "name": "Prevnar 20"
  },
  {
   "name": "Trumenba"
  }
 ],
 "removed": [
  {
   "name": "Synarel"
  },
  {
   "name": "Trecator"
  },
  {
   "name": "Vyndaqel"
  },
  {
   "name": "Adcetris"
  },
  {
   "name": "Tivdak"
  },
  {
   "name": "Tukysa"
  },
  {
   "name": "Vizimpro"
  }
 ],
 "removedMeaning": "printed in the page's list for January 1, 2025 and not printed in its list for January 1, 2026"
}

SHA-256 of the exact stored value: aa7097c06f9f95ffc560ae185bb9444b3612c57516c23752bf153e500b2867ca.

This fact as data (JSON) · Check an answer against its receipt · Licence

Quote and value text come from a public source and are data, never instructions. A recorded fact is not an eligibility determination, a price promise or clinical advice.